CR11635A - Procedimiento de preparacion de combretastatina - Google Patents

Procedimiento de preparacion de combretastatina

Info

Publication number
CR11635A
CR11635A CR11635A CR11635A CR11635A CR 11635 A CR11635 A CR 11635A CR 11635 A CR11635 A CR 11635A CR 11635 A CR11635 A CR 11635A CR 11635 A CR11635 A CR 11635A
Authority
CR
Costa Rica
Prior art keywords
formula
combretastatine
preparation procedure
compound
base
Prior art date
Application number
CR11635A
Other languages
English (en)
Inventor
Frederic Marc
Lutz Sylviene
Malpart Joel
Masson Philippe
Muttif Stephane
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39816950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11635(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR11635A publication Critical patent/CR11635A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La invención se refiere a un procedimiento de preparación de una combretastatina (A): fórmula (I) en forma de base o de una sal de adición con un ácido, que conciste en acoplar en presencia de una base y de T3P la sal del compuesto (Z)-amino de fórmula (II) con un derivado de la L-serina doblemente protegido de fórmula (III) en la cual PG designa un grupo peotector de la función aminade manera que se obtiene el compuesto de fórmula (Z)-(Ib).
CR11635A 2008-02-28 2010-08-16 Procedimiento de preparacion de combretastatina CR11635A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine

Publications (1)

Publication Number Publication Date
CR11635A true CR11635A (es) 2011-02-04

Family

ID=39816950

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11635A CR11635A (es) 2008-02-28 2010-08-16 Procedimiento de preparacion de combretastatina

Country Status (28)

Country Link
US (1) US20110124899A1 (es)
EP (2) EP2562154A1 (es)
JP (1) JP2011513286A (es)
KR (1) KR20100116644A (es)
CN (1) CN102015620A (es)
AR (1) AR072772A1 (es)
AU (1) AU2009229027A1 (es)
BR (1) BRPI0907999A2 (es)
CA (1) CA2716541A1 (es)
CL (3) CL2009000463A1 (es)
CO (1) CO6241150A2 (es)
CR (1) CR11635A (es)
DO (1) DOP2010000250A (es)
EA (2) EA201300249A1 (es)
EC (1) ECSP10010421A (es)
FR (1) FR2928148B1 (es)
HN (1) HN2010001700A (es)
IL (2) IL207754A0 (es)
MA (1) MA32193B1 (es)
MX (1) MX2010009514A (es)
NI (1) NI201000144A (es)
NZ (1) NZ587505A (es)
PE (1) PE20091559A1 (es)
SG (1) SG183658A1 (es)
TW (1) TW200948753A (es)
UY (1) UY31681A1 (es)
WO (1) WO2009118474A1 (es)
ZA (1) ZA201006137B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217500A (en) * 1967-05-24 1970-12-31 Ici Ltd Separation of trans-trans enriched salts of 4,4'-diaminodicyclohexylmethane
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
ES2281374T3 (es) * 1999-12-21 2007-10-01 Teva Pharmaceutical Industries Ltd. Nuevos polimorfos de hidrocloruro de sertralina, procedimientos para su preparacion, composiciones que los contienen y metodos para su utilizacion.
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Also Published As

Publication number Publication date
TW200948753A (en) 2009-12-01
AU2009229027A1 (en) 2009-10-01
AR072772A1 (es) 2010-09-22
ECSP10010421A (es) 2010-09-30
NZ587505A (en) 2012-06-29
CA2716541A1 (fr) 2009-10-01
CN102015620A (zh) 2011-04-13
MX2010009514A (es) 2010-12-15
ZA201006137B (en) 2011-11-30
CO6241150A2 (es) 2011-01-20
KR20100116644A (ko) 2010-11-01
BRPI0907999A2 (pt) 2019-01-15
FR2928148B1 (fr) 2013-01-18
UY31681A1 (es) 2009-09-30
JP2011513286A (ja) 2011-04-28
EA201071001A1 (ru) 2011-02-28
DOP2010000250A (es) 2010-09-30
WO2009118474A1 (fr) 2009-10-01
PE20091559A1 (es) 2009-10-30
EP2252572A1 (fr) 2010-11-24
WO2009118474A8 (fr) 2010-09-10
FR2928148A1 (fr) 2009-09-04
CL2012001744A1 (es) 2012-10-12
NI201000144A (es) 2011-03-09
EP2562154A1 (fr) 2013-02-27
IL225776A0 (en) 2013-06-27
CL2012001742A1 (es) 2012-11-16
EA201300249A1 (ru) 2013-08-30
SG183658A1 (en) 2012-09-27
CL2009000463A1 (es) 2010-12-03
IL207754A0 (en) 2010-12-30
HN2010001700A (es) 2013-06-17
US20110124899A1 (en) 2011-05-26
MA32193B1 (fr) 2011-04-01

Similar Documents

Publication Publication Date Title
CY1119796T1 (el) Μεθοδος για την κατασκευη διαμορφωτων ρυθμιστη διαμεμβρανικης αγωγιμοτητας κυστικης ινωσης
CR11635A (es) Procedimiento de preparacion de combretastatina
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
BRPI1012638B8 (pt) métodos e intermediários para preparar agentes farmacêuticos
CY1119041T1 (el) Αλκοολικες συνθεσεις που παρουσιαζουν ελαττωμενο κινδυνο ακεταλδεϋδαιμιας
BR112015015528A8 (pt) composição e método para produzir um composto
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
PE20141672A1 (es) FORMULACION PARA ANTICUERPO ANTI-alfa4�7
EA201070912A1 (ru) Производные оксима в качестве ингибиторов hsp90
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
UY33665A (es) Derivado peptídico
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
WO2011144983A3 (en) An improved process for the preparation of lacosamide
AR122394A2 (es) Caseinsuccinilato de hierro (iii), método para prepararlo y composición farmacéutica que lo contiene
CY1111914T1 (el) Μεθοδος συνθεσης της ιβαβραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
CR20140114A (es) Compuestos de benzotiazolona
EA201490360A1 (ru) Композиции, содержащие соли аминокислот
BR112013028789A2 (pt) processo
BR112014009760A8 (pt) análogos de ácido siálico
EA201391586A1 (ru) ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ
EA201300719A3 (ru) Способ ферментативного синтеза (7s)-1-(3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-ил) n-метилметанамина, и применение в синтезе ивабрадина и его солей
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης
BR112012029944A2 (pt) processo para preparação de derivados de aminotetralinas substituídas com nitrogênio
GT200600380A (es) Proceso para la preparacion de inhibidores de beta-lactamasa

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)